Download PDF
Z Gastroenterol 2007; 45(10): 1082-1084
DOI: 10.1055/s-2007-963412
Kommentiertes Referat

© Georg Thieme Verlag KG Stuttgart · New York

Gastrointestinale Aspekte bei der Therapie mit dem Standardimmunsuppressivum Mycophenolatmofetil

Gastrointestinal aspects regarding treatment with mycophenolate mofetilH. H.-J. Schmidt1 , J. Brockmann2
  • 1Transplantationshepatologie, Universitätsklinikum Münster, Münster
  • 2Sektion Viszerale Transplantationschirurgie, Universitätsklinikum Münster, Münster
Further Information

Publication History

Publication Date:
09 October 2007 (online)

Also available at
    Permissions and Reprints

Dumortier J, Gagnieu M-C, Salandre J, Guillaud O, Guillem P, Adham M, Boillot O. Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Liver Transplant Patients Presenting Gastrointestinal Disorders: A Pilot Study. Liver Transplantation 2006; 12: 1342 - 1346

Davies NM, Grinyó J, Heading R, Maes B, Meier-Kriesche H-U, Oellerich M. Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. Nephrol Dial Transplant 2007; epub ahead of print

H. H.-J. Schmidt

Transplantationshepatologie, Universitätsklinikum Münster

Domagkstr. 3A

48149 Münster

Phone: ++ 49/2 51-8 35 77 70

Fax: ++ 49/2 51-8 35 77 71

Email: hepar@ukmuenster.de